A preliminary study of (18)F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel

The present explorative study was initiated to evaluate the clinical value of (18)F-FES PET/CT in monitoring the change of estrogen receptor (ER) expression and potential predictive value in metastatic breast cancer patients. Twenty-two pathology-confirmed breast cancer patients were prospectively e...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Chengcheng, Yang, Zhongyi, Sun, Yifei, Zhang, Jian, Zheng, Chunlei, Wang, Leiping, Zhang, Yongping, Xue, Jing, Yao, Zhifeng, Pan, Herong, Wang, Biyun, Zhang, Yingjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529439/
https://www.ncbi.nlm.nih.gov/pubmed/28747642
http://dx.doi.org/10.1038/s41598-017-06903-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529439/
https://www.ncbi.nlm.nih.gov/pubmed/28747642
http://dx.doi.org/10.1038/s41598-017-06903-8

Ejemplares similares